Q heads into the July 4th holiday week with an interesting split: analysts are lifting targets, the stock is up modestly, yet short sellers have been steadily adding exposure even as semcap peers run much harder.
The peer divergence is the sharpest angle here. Semiconductor equipment names broadly had a strong week — AMAT gained 23%, UCTT surged 28%, LRCX added 17%, and even the tightest peer ENTG was up nearly 7%. Q managed just 1.3% on the week and 3.2% on Tuesday's session, closing at $163.31. The stock is participating in the sector move, but only at a fraction of the pace — a relative underperformance that is hard to ignore when correlations to these names run at 70–79%.
The most counterintuitive signal is in short positioning. Shorts have rebuilt meaningfully over the past month despite the stock's gains. Estimated shares short have risen roughly 25% over the past 30 days, with the bulk of that increase clustering around June 24–25, when the count jumped from ~4.0 million to nearly 4.9 million in two sessions. The one-week change is still up 18.5%. Yet the lending market offers no support for a squeeze narrative: availability is essentially unlimited — the pool of shares available to borrow dwarfs what is currently out on loan — and cost to borrow, while up 14.5% on the week to around 0.5%, remains firmly in "easy borrow" territory. Short sellers face no meaningful squeeze pressure here. The ORTEX short score sits at 32.2, near the middle of the range and broadly stable over the past two weeks, suggesting this is deliberate positioning rather than distressed covering or a momentum-driven pile-on.
The Street, however, remains constructively positioned. Mizuho raised its target to $180 from $170 this morning, maintaining its Outperform rating — a second lift from the same firm this year, having moved from $150 in May. RBC Capital has been equally persistent on the upside, pushing its target to $200 after Q1 results in mid-May. The mean consensus target now sits at $174.38, about 7% above the current price, implying the Street still sees room to run. The PE multiple has expanded alongside — it rose ~5.5 points on the week to 38x, and the price-to-book is up around 0.45x over the same stretch to 4.3x. Valuation is not cheap, but the analyst community has not pushed back on it.
Options traders are not showing concern. The put/call ratio came in at 0.33, fractionally below its 20-day average of 0.34, and the z-score is marginally negative. At the 52-week low end of the PCR range (the annual floor is 0.10, the ceiling 1.09), this week's reading is notably call-heavy — options positioning is more bullish than defensive. That sets up a mild contradiction with the rising short interest, where a growing cohort of traders appears to be fading the same rally that options buyers are leaning into.
Insider activity adds a small cautionary footnote. Selling has dominated all recent transactions, with the CEO offloading shares twice in the past few months — 842 shares in May and 4,555 in February. The HR Director and a divisional President also sold in recent weeks. None of the transactions is large in dollar terms, and trade significance scores are all at the floor of 1, suggesting these are likely routine plan-based sales rather than conviction exits. Still, no insider has been buying.
The next scheduled earnings date is August 11. What to watch into that date is whether Q can close the gap on its semcap peers, and whether the recent short-interest build begins to reverse as the sector momentum either sustains or fades.
See the live data behind this article on ORTEX.
Open Q on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
